Cargando…
A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development
The rapid rise of antibiotic resistance is a serious threat to global public health. The situation is exacerbated by the “antibiotics dilemma”: Developing narrow-spectrum antibiotics against resistant bacteria is most beneficial for society, but least attractive for companies, since their usage and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023703/ https://www.ncbi.nlm.nih.gov/pubmed/35451653 http://dx.doi.org/10.1007/s11538-022-01013-7 |